S&P 500   2,971.10 (+0.03%)
DOW   26,854.60 (+0.14%)
QQQ   191.51 (+0.21%)
AAPL   237.48 (+0.54%)
FB   184.11 (-0.04%)
MSFT   139.98 (+0.21%)
CGC   18.98 (-2.32%)
NVDA   185.91 (-0.04%)
BABA   171.73 (-0.71%)
GE   8.75 (-0.57%)
TSLA   255.68 (+3.14%)
T   37.44 (-0.37%)
F   8.81 (+0.34%)
NFLX   283.09 (+0.06%)
BAC   29.12 (+0.73%)
GILD   64.83 (+1.31%)
DIS   129.72 (-0.23%)
S&P 500   2,971.10 (+0.03%)
DOW   26,854.60 (+0.14%)
QQQ   191.51 (+0.21%)
AAPL   237.48 (+0.54%)
FB   184.11 (-0.04%)
MSFT   139.98 (+0.21%)
CGC   18.98 (-2.32%)
NVDA   185.91 (-0.04%)
BABA   171.73 (-0.71%)
GE   8.75 (-0.57%)
TSLA   255.68 (+3.14%)
T   37.44 (-0.37%)
F   8.81 (+0.34%)
NFLX   283.09 (+0.06%)
BAC   29.12 (+0.73%)
GILD   64.83 (+1.31%)
DIS   129.72 (-0.23%)
Log in

Phibro Animal Health Stock Price, News & Analysis (NASDAQ:PAHC)

$21.38
+0.25 (+1.18 %)
(As of 10/14/2019 11:43 AM ET)
Today's Range
$20.95
Now: $21.38
$21.41
50-Day Range
$20.27
MA: $22.49
$31.92
52-Week Range
$20.00
Now: $21.38
$44.99
Volume987 shs
Average Volume223,795 shs
Market Capitalization$864.82 million
P/E Ratio13.99
Dividend Yield2.29%
Beta0.88
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PAHC
CUSIPN/A
Phone201-329-7300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$828 million
Cash Flow$2.28 per share
Book Value$5.34 per share

Profitability

Net Income$54.71 million

Miscellaneous

Employees1,600
Market Cap$864.82 million
Next Earnings Date11/5/2019 (Estimated)
OptionableOptionable

Receive PAHC News and Ratings via Email

Sign-up to receive the latest news and ratings for PAHC and its competitors with MarketBeat's FREE daily newsletter.


Phibro Animal Health (NASDAQ:PAHC) Frequently Asked Questions

What is Phibro Animal Health's stock symbol?

Phibro Animal Health trades on the NASDAQ under the ticker symbol "PAHC."

How often does Phibro Animal Health pay dividends? What is the dividend yield for Phibro Animal Health?

Phibro Animal Health announced a quarterly dividend on Monday, July 29th. Stockholders of record on Wednesday, September 4th will be given a dividend of $0.12 per share on Wednesday, September 25th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.24%. The ex-dividend date of this dividend is Tuesday, September 3rd. View Phibro Animal Health's Dividend History.

How were Phibro Animal Health's earnings last quarter?

Phibro Animal Health Corp (NASDAQ:PAHC) posted its earnings results on Tuesday, August, 27th. The company reported $0.33 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.34 by $0.01. The company earned $203.90 million during the quarter, compared to the consensus estimate of $206 million. Phibro Animal Health had a return on equity of 29.99% and a net margin of 6.59%. The firm's revenue for the quarter was down 3.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.46 EPS. View Phibro Animal Health's Earnings History.

When is Phibro Animal Health's next earnings date?

Phibro Animal Health is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Phibro Animal Health.

What guidance has Phibro Animal Health issued on next quarter's earnings?

Phibro Animal Health issued an update on its FY20 earnings guidance on Tuesday, August, 27th. The company provided earnings per share guidance of $1.08 -1.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.66. The company issued revenue guidance of $833 -863 million, compared to the consensus revenue estimate of $857.96 million.

What price target have analysts set for PAHC?

5 Wall Street analysts have issued 12-month price objectives for Phibro Animal Health's stock. Their predictions range from $18.00 to $42.00. On average, they anticipate Phibro Animal Health's share price to reach $26.60 in the next year. This suggests a possible upside of 24.4% from the stock's current price. View Analyst Price Targets for Phibro Animal Health.

What is the consensus analysts' recommendation for Phibro Animal Health?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last year. There are currently 2 sell ratings, 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Phibro Animal Health.

Has Phibro Animal Health been receiving favorable news coverage?

News headlines about PAHC stock have trended negative on Monday, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Phibro Animal Health earned a media sentiment score of -2.6 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Phibro Animal Health.

Are investors shorting Phibro Animal Health?

Phibro Animal Health saw a drop in short interest in the month of September. As of September 30th, there was short interest totalling 623,400 shares, a drop of 5.9% from the August 30th total of 662,400 shares. Based on an average daily volume of 225,000 shares, the short-interest ratio is currently 2.8 days. Approximately 3.1% of the shares of the stock are sold short. View Phibro Animal Health's Current Options Chain.

Who are some of Phibro Animal Health's key competitors?

What other stocks do shareholders of Phibro Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Intercept Pharmaceuticals (ICPT), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Zoetis (ZTS), Booking (BKNG), Ophthotech (OPHT) and RetailMeNot (SALE).

Who are Phibro Animal Health's key executives?

Phibro Animal Health's management team includes the folowing people:
  • Mr. Jack Clifford Bendheim, Chairman, Pres & CEO (Age 72)
  • Mr. Larry L. Miller, Chief Operating Officer (Age 55)
  • Mr. Dean J. Warras, Pres of Animal Health & Nutrition - North America (Age 50)
  • Mr. Richard G. Johnson, Chief Financial Officer (Age 70)
  • Mr. Thomas G. Dagger, Sr. VP, Gen. Counsel & Corp. Sec. (Age 61)

Who are Phibro Animal Health's major shareholders?

Phibro Animal Health's stock is owned by a variety of of institutional and retail investors. Top institutional investors include State of Alaska Department of Revenue (0.04%). Company insiders that own Phibro Animal Health stock include Bfi Co, Llc, Daniel M Bendheim, Dean J Warras, E Thomas Corcoran, Jack Bendheim and Larry Lee Miller. View Institutional Ownership Trends for Phibro Animal Health.

Which major investors are buying Phibro Animal Health stock?

PAHC stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. View Insider Buying and Selling for Phibro Animal Health.

How do I buy shares of Phibro Animal Health?

Shares of PAHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Phibro Animal Health's stock price today?

One share of PAHC stock can currently be purchased for approximately $21.39.

How big of a company is Phibro Animal Health?

Phibro Animal Health has a market capitalization of $865.23 million and generates $828 million in revenue each year. The company earns $54.71 million in net income (profit) each year or $1.53 on an earnings per share basis. Phibro Animal Health employs 1,600 workers across the globe.View Additional Information About Phibro Animal Health.

What is Phibro Animal Health's official website?

The official website for Phibro Animal Health is http://www.pahc.com/.

How can I contact Phibro Animal Health?

Phibro Animal Health's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The company can be reached via phone at 201-329-7300 or via email at [email protected]


MarketBeat Community Rating for Phibro Animal Health (NASDAQ PAHC)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  255 (Thanks for Voting!)
Underperform Votes:  314 (Thanks for Voting!)
Total Votes:  569
MarketBeat's community ratings are surveys of what our community members think about Phibro Animal Health and other stocks. Vote "Outperform" if you believe PAHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PAHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/14/2019 by MarketBeat.com Staff

Featured Article: Elliott Wave Theory

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel